NCT06782906

Brief Summary

Non-healthy eating habits and a lack of exercise contribute to prediabetes and type 2 diabetes (T2D). Evening snacking is linked to abnormal weight gain in adults and healthy adolescents. Most adolescents do not get enough exercise. This study aims to look at the benefits of more exercise and stopping evening snacking in youth with prediabetes. The study lasts 8 weeks, and participants will be randomly assigned to either an intervention group or a standard of care group.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
39mo left

Started May 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress24%
May 2025Sep 2029

First Submitted

Initial submission to the registry

January 7, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

January 20, 2025

Completed
4 months until next milestone

Study Start

First participant enrolled

May 13, 2025

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2029

Last Updated

May 14, 2025

Status Verified

May 1, 2025

Enrollment Period

4.3 years

First QC Date

January 7, 2025

Last Update Submit

May 12, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Insulin sensitivity index for glucose disposal (ISI [Gly]) during oral glucose tolerance test

    Insulin sensitivity index for glycemia (ISI \[Gly\]) will be calculated with a formula using insulin and glucose area under the curves during oral glucose tolerance tests (OGTT) as described previously (Belfiore et al., Metabolism, 2001): ISI (Gly) = 2 / \[INSp x GLYp) + 1\] INSp: insulinemic area during OGTT with 3 (0, 1h and 2h) or 5 sampling (0, 30, 60, 90 and 120 min) GLYp: glycemic area during OGTT (0, 1h and 2h) or 5 sampling (0, 30, 60, 90 and 120 min) INSp and GLYp are expressed by taking the mean normal value as 1, i.e., by dividing the value observed in the person under study by the mean normal value so that, if INSp (or GLYp) is 1.5-fold the mean normal values, it will be considered as equal to 1.5, and so on. We will use appropriate "mean normal values," which will be derived from data obtained in our laboratory.

    At week 9-10 following completion of 8 weeks of intervention period

Secondary Outcomes (10)

  • index for fat disposal (ISI [FFA]) during oral glucose tolerance test

    At week 9-10 following completion of 8 weeks of intervention period

  • HbA1c

    At week 9-10 following completion of 8 weeks of intervention period

  • Percentage of adiposity (percent body fat)

    At week 9-10 following completion of 8 weeks of intervention period

  • Amino acid concentrations

    At week 9-10 following completion of 8 weeks of intervention period

  • Adiponectin

    At week 9-10 following completion of 8 weeks of intervention period

  • +5 more secondary outcomes

Study Arms (2)

Intervention Arm

EXPERIMENTAL

Participants in the intervention arm will be asked to perform ≥10,000 daily steps (≥5 days/week) and omit evening snacking after 8:00 p.m.

Behavioral: ≥10,000 daily steps (≥5 days/week) and stopping evening snacking

Standard of Care Arm

NO INTERVENTION

Participants in the standard of care arm will be asked to follow recommendations of their physician.

Interventions

Participants in the intervention arm will be asked to perform ≥10,000 daily steps (≥5 days/week) and omit evening snacking after 8:00 p.m.

Intervention Arm

Eligibility Criteria

Age12 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • years of age
  • Having a diagnosis of prediabetes
  • Engaging in frequent evening snacking
  • Inadequate physical activity

You may not qualify if:

  • Diagnosis of diabetes
  • Significant history of chronic disease
  • Evidence of significant liver or kidney disease;
  • Any hormone replacement therapy; and
  • Pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Texas Children's Hospital / Children's Nutrition Research Center / Baylor College of Medicine

Houston, Texas, 77030, United States

RECRUITING

MeSH Terms

Conditions

Prediabetic State

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Mustafa Tosur, MD

    Baylor College of Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mustafa Tosur, MD

CONTACT

Lori Malone

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

January 7, 2025

First Posted

January 20, 2025

Study Start

May 13, 2025

Primary Completion (Estimated)

September 1, 2029

Study Completion (Estimated)

September 1, 2029

Last Updated

May 14, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations